SSR4 and intraepithelial neoplasia: In our previous study, signal sequence receptor subunit delta (SSR4) was involved in a prognostic ESCC model (6), which was constructed with the glucose metabolism gene set because the cellular glycogen is lost in the early stages (mild squamous dysplasia or low-grade intraepithelial neoplasia) and continues until invasive ESCC.